Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1860-2002

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase ; day:3 ; month:3 ; year:2021 ; pages:1-11
Molecular imaging & biology ; (3.3.2021), 1-11

Creator: Gentzsch, Christian
Chen, Xinyu
Spatz, Philipp
Košak, Urban
Knez, Damijan
Nose, Naoko
Gobec, Stanislav
Higuchi, Takahiro
Decker, Michael

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11307-021-01584-2

URN: urn:nbn:de:101:1-2021041707593528809630

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gentzsch, Christian
Chen, Xinyu
Spatz, Philipp
Košak, Urban
Knez, Damijan
Nose, Naoko
Gobec, Stanislav
Higuchi, Takahiro
Decker, Michael
SpringerLink (Online service)

Other Objects (12)

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Hochschulschrift

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Hochschulschrift

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Hochschulschrift

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System

Synthesis and initial characterization of a reversible, selective 18F-labeled radiotracer for human butyrylcholinesterase

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter

Radionuclide imaging of neurohormonal system of the heart

Synthesis and initial characterization of a selective, pseudo‐irreversible inhibitor of human butyrylcholinesterase as PET tracer

Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine

Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents

Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers

Small Molecule Intervention for Inflammation: Utilising GPCR Ligands and Butyrylcholinesterase Inhibitors in Diagnosis and Therapy

Related objects

Reset password